dacarbazine and Myeloproliferative Disorders

dacarbazine has been researched along with Myeloproliferative Disorders in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Berg, A; Kolesar, J; Mehta, M; Petrich, RJ; Steen, P; Sylvester, RK; Tate, JM	1

Other Studies

1 other study(ies) available for dacarbazine and Myeloproliferative Disorders

Article	Year
Temozolomide-induced severe myelosuppression: analysis of clinically associated polymorphisms in two patients. Anti-cancer drugs, 2011, Volume: 22, Issue:1 Topics: Adult; Antineoplastic Agents, Alkylating; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Dacarbazine; Female; Glioma; Glutathione S-Transferase pi; Humans; Male; Middle Aged; Myeloproliferative Disorders; NAD(P)H Dehydrogenase (Quinone); Neoplasms, Neuroepithelial; O(6)-Methylguanine-DNA Methyltransferase; Patients; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Temozolomide	2011

Article

Year

Temozolomide-induced severe myelosuppression: analysis of clinically associated polymorphisms in two patients.

Anti-cancer drugs, 2011, Volume: 22, Issue:1

Topics: Adult; Antineoplastic Agents, Alkylating; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Dacarbazine; Female; Glioma; Glutathione S-Transferase pi; Humans; Male; Middle Aged; Myeloproliferative Disorders; NAD(P)H Dehydrogenase (Quinone); Neoplasms, Neuroepithelial; O(6)-Methylguanine-DNA Methyltransferase; Patients; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Temozolomide

2011